Table 2 Surface plasmon resonance analysis of the interactions between D-C-G3, SpA, SpG or D-C and hIgG, rIgG, gIgG, mIgG1, mIgG2a, mIgG2b or mIgG3

From: In vitro molecular evolution yields an NEIBM with a potential novel IgG binding property

  

Analyte

Ligand

Constant

mIgG1

mIgG2a

mIgG2b

mIgG3

Human IgG

Rabbit IgG

Goat IgG

DCG3

ka(M−1s−1)

1.318 × 105

1.445 × 106

2.168 × 105

3.364 × 105

1.318 × 106

4.132 × 105

3.147 × 105

 

kd(s−1)

1.923 × 10−4

1.444 × 10−5

1.389 × 10−4

1.511 × 10−4

8.790 × 10−7

2.377 × 10−5

6.520 × 10−5

 

KA(M−1)

6.85 × 108

1.00 × 1011

1.56 × 109

2.23 × 109

1.50 × 1012

1.74 × 1010

4.83 × 109

DC

ka(M−1s−1)

3.474 × 104

1.554 × 106

6.789 × 104

6.783 × 105

1.161 × 106

6.118 × 105

1.238 × 105

 

kd(s−1)

4.283 × 10−4

5.696 × 10−4

3.890 × 10−4

5.378 × 10−4

2.762 × 10−5

1.069 × 10−4

5.662 × 10−4

 

KA(M−1)

8.11 × 107

2.73 × 109

1.75 × 108

1.26 × 109

4.20 × 1010

5.72 × 109

2.19 × 108

SpA

ka(M−1s−1)

6.034 × 104

1.531 × 106

1.142 × 105

2.516 × 105

9.63 × 105

6.470 × 105

1.295 × 105

 

kd(s−1)

3.698 × 10−4

3.155 × 10−4

3.578 × 10−4

3.142 × 10−4

1.156 × 10−5

2.300 × 10−5

8.497 × 10−4

 

KA(M−1)

1.63 × 108

4.85 × 109

3.19 × 108

8.01 × 108

8.34 × 1010

2.81 × 1010

1.52 × 108

SpG

ka(M−1s−1)

9.295 × 104

1.089 × 106

1.212 × 105

2.346 × 105

1.747 × 106

1.240 × 106

7.160 × 105

 

kd(s−1)

7.426 × 10−4

5.762 × 10−4

5.983 × 10−4

4.723 × 10−4

2.615 × 10−5

3.190 × 10−5

1.243 × 104

 

KA(M−1)

1.25 × 108

1.89 × 109

2.03 × 108

4.97 × 108

6.68 × 1010

3.88 × 1010

5.76 × 109

KADCG3/KADC

8.45

36.64

8.94

1.76

35.70

3.04

22.26

KADCG3/KASpA

4.20

20.6

4.90

2.78

17.99

0.62

31.69